MyAverix Finance
TWO · Healthcare
Meribank Biotech Co., Ltd (4724)
Biotechnology
Meribank Biotech Co., Ltd (4724) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4724
Meribank Biotech Co., Ltd (4724) — FAQ
What is 4724's P/E ratio?
The price-to-earnings (P/E) ratio for Meribank Biotech Co., Ltd (4724) is 25.00 (data as of 2026-05-23).
Does Meribank Biotech Co., Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Meribank Biotech Co., Ltd (4724). Check the MyAverix Finance app for the latest dividend data.
What sector is Meribank Biotech Co., Ltd in?
Meribank Biotech Co., Ltd (4724) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 4724 listed on?
4724 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.